Research Article
A Network Investigation on Idiopathic Hypogonadotropic Hypogonadism in China
Table 1
Different therapeutic protocols that IHH patients received.
| | Therapeutic protocols | Number |
| | Androgen (2 years) + HCG (3 years) | 6 | | Androgen (8 years) + HCG (8 years) | 3 | | Androgen (1 year) + HCG (2 years) + HMG (1 year) | 1 | | Androgen (1 year) + HCG (1 year) + HMG (2 years) | 3 | | Androgen (2 years) + HCG (1 year) + HMG (2 years) | 3 | | Androgen (2 years) + HCG (3 years) + HMG (2 years) | 3 | | Androgen (2 years) + HCG (7 years) + HMG (4 years) | 2 | | Androgen (2 years) + HCG (7 years) + HMG (7 years) | 4 | | Androgen (2 years) + HCG (17 years) + LHRH (3 years) | 3 | | Androgen (1 year) + HCG (4 years) + HMG (2 years) + LHRH (2 years) | 3 | | HCG (2 years) | 3 | | HCG (3 years) | 3 | | HCG (8 years) | 1 | | HCG (2 years) + HMG (1 year) | 11 | | HCG (2 years) + HMG (2 years) | 7 | | HCG (3 years) + HMG (2 years) | 8 | | HCG (4 years) + HMG (4 years) | 3 | | HCG (10 years) + HMG (10 years) | 1 |
| | Total | 68 |
|
|
HCG: human chorionic gonadotropin; HMG: human menopausal gonadotropin; LHRH: luteinizing-hormone-releasing hormone.
|
